ProfileGDS4718 / 214384_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 65% 59% 63% 63% 51% 53% 60% 61% 59% 60% 60% 54% 49% 50% 58% 61% 52% 56% 55% 61% 58% 61% 67% 60% 50% 63% 54% 69% 53% 54% 46% 67% 64% 54% 52% 54% 58% 61% 58% 64% 51% 45% 45% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5698266
GSM549102patient 115, normal, homogenized [OPG study]6.4586165
GSM549104patient 119, normal, homogenized [OPG study]6.078959
GSM549108patient 138, normal, homogenized [OPG study]6.3293463
GSM549119patient 077, normal, homogenized [OPG study]6.3158363
GSM549133patient 032, cancer, homogenized [OPG study]5.5361851
GSM549139patient 042, cancer, homogenized [OPG study]5.6610653
GSM549099patient 107, normal, homogenized [OPG study]6.1160560
GSM549109patient 139, normal, homogenized [OPG study]6.1876261
GSM549110patient 046, normal, homogenized [OPG study]6.0478159
GSM549114patient 063, normal, homogenized [OPG study]6.0961860
GSM549122patient 082, normal, homogenized [OPG study]6.1121660
GSM549134patient 033, cancer, homogenized [OPG study]5.7347854
GSM549136patient 036, cancer, homogenized [OPG study]5.3810949
GSM549140patient 044, cancer, homogenized [OPG study]5.4983350
GSM549111patient 047, normal, homogenized [OPG study]5.9723358
GSM549113patient 057, normal, homogenized [OPG study]6.1458161
GSM549132patient 031, cancer, homogenized [OPG study]5.6439952
GSM549137patient 038, cancer, homogenized [OPG study]5.8433656
GSM549142patient 047, cancer, homogenized [OPG study]5.9131855
GSM549100patient 110, normal, homogenized [OPG study]6.2020761
GSM549107patient 135, normal, homogenized [OPG study]5.9886558
GSM549115patient 068, normal, homogenized [OPG study]6.1745661
GSM549116patient 072, normal, homogenized [OPG study]6.6494567
GSM549120patient 078, normal, homogenized [OPG study]6.1435560
GSM549131patient 030, cancer, homogenized [OPG study]5.4816850
GSM549118patient 074, normal, homogenized [OPG study]6.3531263
GSM549129patient 027, cancer, homogenized [OPG study]5.7984254
GSM549123patient 088, normal, homogenized [OPG study]6.8093269
GSM549124patient 006, cancer, homogenized [OPG study]5.72353
GSM549126patient 015, cancer, homogenized [OPG study]5.7135254
GSM549128patient 025, cancer, homogenized [OPG study]5.3002646
GSM549103patient 117, normal, homogenized [OPG study]6.6050167
GSM549117patient 073, normal, homogenized [OPG study]6.3653464
GSM549138patient 041, cancer, homogenized [OPG study]5.7524154
GSM549141patient 045, cancer, homogenized [OPG study]5.6040352
GSM549130patient 028, cancer, homogenized [OPG study]5.7245454
GSM549101patient 111, normal, homogenized [OPG study]5.9985658
GSM549105patient 128, normal, homogenized [OPG study]6.2147261
GSM549106patient 134, normal, homogenized [OPG study]5.9597158
GSM549112patient 048, normal, homogenized [OPG study]6.3801164
GSM549125patient 011, cancer, homogenized [OPG study]5.5679251
GSM549127patient 024, cancer, homogenized [OPG study]5.2258345
GSM549135patient 035, cancer, homogenized [OPG study]5.211345